Bryan White
@bryan_p_white
Followers
722
Following
10K
Media
371
Statuses
2K
RT @kcmolinaID: Proud to see our Mandells PPID chapter on the antibiotic pipeline published. A huge career bucket list item for me since I….
0
2
0
RT @LauraB_PharmD: We are recruiting for a 4th inpatient ID pharmacist to join our team at Vanderbilt! We work with amazing providers, prec….
0
4
0
RT @julie_justo: It’s out! IDSA #cUTI guidelines 7/17/25. Now the fun begins….😌 #IDTwitter #TwitteRx @IDSAInfo .
idsociety.org
0
16
0
RT @JosephSassineMD: ID fellowship applicants, make sure to check out our program @OUCollegeofMed:.2 year clinical program - 3 tracks (TxID….
0
5
0
RT @ABsteward: Taxonomy shift 🚨.Candida auris has been reclassified as Candidozyma auris (C auris ) to reflect its distinct genetic profile….
0
43
0
RT @OURxResidency: 🎉Please join us in welcoming Residency Class of 2026!. Today marks the start of a new residency year, and we are thrille….
0
1
0
RT @OURxResidency: 🎓 Congrats to our Residency Class of 2025! We’re so proud of all you’ve accomplished and can’t wait to see what’s next.….
0
2
0
RT @JosephSassineMD: Out now in @jac_amr, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great @Emily_S….
academic.oup.com
Abstract. Bloodstream infections due to yeast are associated with a high mortality rate. There is a lack of data that evaluate the real-world sensitivity o
0
7
0
RT @blandman19: Super job by my @UGAPharmacy colleague @DBChastain leading this review (FREE Open Access): Adjunctive β-lactams for Staphyl….
journals.sagepub.com
Staphylococcus aureus bacteremia (SAB) remains a major clinical challenge, with persistently high mortality despite advancements in antimicrobial therapy. The e...
0
6
0
RT @JosephSassineMD: Invasive fusariosis after CAR T is rare but can be consequential. Here’s our case of cutaneous fusariosis after CD19 C….
journals.asm.org
Invasive fusariosis is a rare entity that primarily affects patients with hematological malignancies and recipients of hematopoietic cell transplants. Cases of mold infections in chimeric antigen...
0
10
0
RT @zacroBID: Our real world study is the 1st (to our knowledge) to detail widespread restriction of remdesivir with patients that represen….
academic.oup.com
This pre-post quasi-experimental study evaluated the impact of a remdesivir restriction. Post-intervention, remdesivir was available for symptomatic immuno
0
15
0
RT @OURxResidency: Welcome our newest Pharmacy Residents — the Residency Class of 2026! . A big congratulations as well to our current PGY….
0
2
0
@DrToddLee @DrEmilyMcD Randomized 275 patients. Median age of 63, 1/3 of patients were outpatient, 1/2 of patients were on PPIs, included patients with IBD. 99% of superiority at day 36, but curves overlap by day 90. #ESCMIDGlobal2025
1
1
6
@DrToddLee @DrEmilyMcD Included adult patients and excluded patients who got treatments other than vancomycin. Randomized to taper or placebo after 14 days of treatment. Primary outcome of recurrence at 56 days. #ESCMIDGlobal2025
1
0
3
Last study for me, vancomycin taper for CDI @DrToddLee & @DrEmilyMcD. 1/3 of patients with CDI recurr. Worse outcomes with recurrence. Limited data for where the 10 day duration came from. Thought that a brief taper to decrease recurrence early. #ESCMIDGlobal
2
2
10
No difference in interim analysis. No difference in high viral load or low CD4 count group. A decent numerical difference in the per protocol group. Viral loads decreased rapidly. Interim analysis of small study, but may be able to do 2 drugs in HIV & TB. #ESCMIDGlobal2025
1
0
1
Up next double dose dolutegravir and lamuvidine vs efavirenz/tdf/lamuvidine for HIV patients with TB. DDIs with ART and TB. Included 107 patients so far and followed for 48 weeks. No exclusions based on CD4 or viral load. Primary outcome of viral suppression. #ESCMIDGlobal
3
0
1
Up next, FMT to decrease AMR in liver cirrhosis patients. More diversity and less vancomycin resistance in GI microbiome. #ESCMIDGlobal2025
1
0
0
Primary outcome of death or functional deterioration. 32 included. No difference overall. Less morality in plasma group. The mortality difference was more pronounced in immunocompromised patients and in high titer. #ESCMIDGlobal2025
1
0
0